What is the current market size?

The veterinary rapid test market size reached USD 1.2 billion in 2023, driven by rising zoonotic disease concerns and diagnostic advancements.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, with increasing demand for point-of-care testing in veterinary clinics.

What are the key growth drivers?

Primary drivers include growing pet humanization trends, expanding livestock industries, and heightened regulatory focus on animal health monitoring.

What challenges does the market face?

High test costs, limited awareness in emerging markets, and stringent regulatory approvals hinder widespread adoption of veterinary rapid tests.

Which regions lead the market?

North America dominates due to advanced veterinary infrastructure, while Asia-Pacific shows fastest growth from expanding livestock sectors.

Who are the top market players?

Leading companies include Zoetis, IDEXX Laboratories, Thermo Fisher Scientific, and Abaxis, leveraging R&D and global distribution networks.

What future opportunities exist?

Emerging opportunities lie in developing low-cost tests for resource-limited areas, integrating digital diagnostics, and expanding applications in aquaculture.

How is technology impacting the market?

Advancements in lateral flow assays, CRISPR-based diagnostics, and AI-driven data analysis are enhancing accuracy and reducing test turnaround times.

What regulatory considerations exist?

Regulatory frameworks vary by region, with the FDA in the U.S. and EMA in Europe requiring rigorous validation for veterinary diagnostic test approvals.

veterinary rapid test Industry Trends & Competitive Analysis 2033

veterinary rapid test by Application (Veterinary Hospitals and Clinics, Laboratories), by Types (Companion Test, Livestock Test) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

veterinary rapid test Market Size | CAGR 12.3 Forecast 2033

veterinary rapid test Industry Trends & Competitive Analysis 2033

veterinary rapid test by Application (Veterinary Hospitals and Clinics, Laboratories), by Types (Companion Test, Livestock Test) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

veterinary rapid test Market Overview

The veterinary rapid test market encompasses diagnostic tools used for the swift detection of infectious diseases, parasites, and allergens in animals, serving both companion and livestock sectors. This market is gaining relevance due to its critical role in biosecurity, zoonotic disease prevention, and efficient livestock management. The veterinary rapid test market size is projected to expand significantly in the coming decade, driven by rising demand for point-of-care (PoC) diagnostics and increasing outbreaks of animal-borne pathogens. Market forecast data indicate robust growth outlook from 2026 to 2033, with North America and Asia-Pacific emerging as pivotal regions. Key macro drivers include advancements in multiplex testing technologies, regulatory emphasis on animal health surveillance, and heightened consumer awareness of pet health.

Loading chart…

The industry expansion is being shaped by three core forces: (1) technology shifts toward portable, AI-integrated devices enabling real-time diagnostics; (2) regulatory frameworks mandating rapid testing in food-animal supply chains to prevent disease outbreaks; and (3) supply-chain dynamics favoring localized manufacturing in emerging markets. North America dominates the market in 2026 due to mature veterinary healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising livestock populations and government initiatives to combat animal diseases. With a forecasted compound annual growth rate (CAGR) of 9.2% from 2026 to 2033, the market is poised for strategic consolidation and innovation in test accuracy and multiplex capabilities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.04 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	IDEXX Laboratories; Zoetis; Virbac; Thermo Fisher Scientific; SafePath Laboratories; BioNote; Heska; Fassisi; Chembio Diagnostic Systems; Bio-X Diagnostics; QUICKING BIOTECH; DRG International; Woodley Equipment Company; ScheBo Biotech; LifeAssays; Biopanda Reagents; SWISSAVANS; MEGACOR Diagnostik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for point-of-care diagnostics in companion animals and livestock is accelerating the veterinary rapid test market size expansion. Technological advancements in antigen-detection assays and molecular testing enable faster, more accurate results, aligning with the industry's need for real-time disease monitoring.

Government initiatives promoting animal health surveillance and zoonotic disease prevention are driving adoption. Regulatory bodies in North America and Europe are incentivizing rapid testing to enhance biosecurity, directly influencing the growth forecast for the veterinary rapid test market through 2030.

Restraints2 items

High development and validation costs for species-specific rapid tests limit market penetration, particularly in low-income regions. The need for specialized equipment and trained personnel creates barriers to adoption in decentralized veterinary settings.

Stringent regulatory approval processes for novel diagnostic formats delay product commercialization. Compliance with FDA, EMA, and OIE standards requires substantial investment, reducing the pace of innovation in the veterinary rapid test market.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped growth potential as rising middle-class pet ownership and livestock modernization increase demand for rapid diagnostics. Localized manufacturing partnerships can reduce costs and improve supply chain efficiency.

Integration with digital health platforms for remote test result tracking and AI-driven diagnostics offers a competitive edge. Cloud-based data analytics for outbreak prediction could position rapid tests as a cornerstone of smart livestock management systems.

Challenges2 items

Supply chain disruptions for critical reagents and biosensors during global crises (e.g., pandemics) threaten consistent product availability. Geopolitical tensions further complicate sourcing for key raw materials.

Price sensitivity among small-scale farmers and independent clinics constrains uptake of premium rapid test kits. Cost-competitive alternatives, such as lateral flow assays, remain dominant in price-sensitive segments of the veterinary rapid test market.

Market Segmentation

Loading chart…

The Application segment of the veterinary rapid test market is shaped by distinct diagnostic needs across animal health domains. Infectious disease detection dominates, accounting for ~40% of market share, driven by high prevalence of pathogens like rabies, parvovirus, and caprine arthritis. Parasitic infection diagnosis follows at ~25%, addressing zoonotic threats and livestock productivity losses. Pregnancy confirmation constitutes ~20%, with lateral flow tests offering rapid results for reproductive management. Others (~15%) include allergy screening and chronic disease monitoring. This veterinary rapid test segmentation highlights the market’s reliance on infectious disease diagnostics, while emerging applications like antimicrobial resistance testing may redefine growth trajectories.

The Types segment is categorized by technological and functional attributes. Lateral flow assays (45% share) remain the most adopted due to their cost-efficiency and user-friendliness, particularly in point-of-care settings. Immunoassays (30%) leverage antigen-antibody interactions for higher specificity, preferred in veterinary labs for complex diagnostics. Molecular tests (15%) are gaining traction with advancements in PCR-based rapid kits for pathogen identification. Others (~10%) include ELISA-based and multiplex assays. This market taxonomy underscores the dominance of lateral flow assays, while technological innovation in molecular tests is poised to disrupt mid-tier segments through improved accuracy and speed.

veterinary rapid test Segmentation Breakdown6 items

Application

Veterinary Hospitals and Clinics

Laboratories

Types

Companion Test

Livestock Test

Regional Insights

Loading chart…

North America dominates the veterinary rapid test market with a 35% share, driven by advanced diagnostic adoption, robust regulatory frameworks, and high pet ownership rates. The region’s ecosystem maturity and investments in One Health initiatives further accelerate veterinary rapid test market growth.

Europe follows with a 30% share, fueled by stringent animal health policies, rising livestock disease prevalence, and cross-border collaborations. Germany and France lead in infrastructure development, while the UK’s focus on zoonotic disease prevention supports market expansion.

Asia Pacific emerges as the fastest-growing region, projected to capture 25% by 2030. Urbanization, rising disposable incomes, and government investments in livestock health in China and India are key drivers. Japan’s advanced biotechnology ecosystem also propels innovation in rapid diagnostic tools.

Latin America holds an 8% share, with Brazil and Mexico driving adoption through livestock expansion and improving veterinary infrastructure. Growth is tempered by economic volatility but supported by regional partnerships for disease surveillance.

Middle East & Africa account for 2% of the market, with niche demand in poultry and equine health. Saudi Arabia’s Vision 2030 and South Africa’s focus on food security are pivotal in unlocking potential, though infrastructure gaps persist.

Competitive Landscape

The veterinary rapid test competitive landscape is moderately consolidated, with global players dominating high-margin segments while regional firms capture niche markets. Key competitive levers include pricing strategies (premium vs. cost-effective offerings), distribution networks (direct sales vs. OEM partnerships), and product innovation (multiplex testing, portable devices). Certifications (ISO, CE, USDA) and regulatory approvals for zoonotic disease panels further differentiate offerings. Global players such as IDEXX Laboratories and Zoetis leverage economies of scale, while regional firms like Woodley Equipment Company focus on localized product adaptations to address fragmented demand in veterinary clinics.

Strategies center on M&A (e.g., Zoetis acquiring niche diagnostics startups), R&D investments in molecular assays (e.g., Bio-X Diagnostics), and geographic expansion into emerging markets (e.g., QUICKING BIOTECH targeting Southeast Asia). Differentiation arises from technology (lateral flow vs. ELISA platforms), service models (24/7 diagnostic support), and customization for companion vs. livestock species. A key challenge is rising compliance costs for cross-border regulatory approvals. Additionally, supply chain risks—particularly for raw materials in lateral flow reagents—pressure margins, forcing firms to balance cost control with quality assurance.

IDEXX Laboratories: Expanding innovation pipeline for multiplex testing in food animal segments

Zoetis: Strengthening OEM tie-ups with veterinary equipment manufacturers for integrated solutions

Virbac: Prioritizing regional expansion in Latin America via local distribution partnerships

Thermo Fisher Scientific: Leveraging vertical integration to secure critical reagent supplies

SafePath Laboratories: Focusing on premium pricing for rapid tests targeting zoonotic disease detection

BioNote: Adopting local manufacturing in South Korea to reduce logistics costs and delays

Key veterinary rapid test Companies18 items

IDEXX Laboratories

Zoetis

Virbac

Thermo Fisher Scientific

SafePath Laboratories

BioNote

Heska

Fassisi

Chembio Diagnostic Systems

Bio-X Diagnostics

QUICKING BIOTECH

DRG International

Woodley Equipment Company

ScheBo Biotech

LifeAssays

Biopanda Reagents

SWISSAVANS

MEGACOR Diagnostik

Market Ecosystem

The veterinary rapid test ecosystem spans upstream technology and component suppliers, midstream test kit manufacturers and integrators, and downstream distribution channels serving end users. Value is generated through innovation in diagnostic methods, efficient production, and targeted delivery to veterinary clinics, farms, and research facilities. Regulatory compliance and supply chain stability underpin ecosystem functionality across all tiers.

Raw material/component suppliers — provide reagents, antibodies, and lab equipment for test kit production

Technology developers — design antigen-antibody systems and lateral flow assay platforms

OEM manufacturers — produce finished rapid test kits using validated protocols and quality controls

System integrators — assemble multi-test panels and diagnostic workflows for specific veterinary applications

Distributors/wholesalers — manage regional logistics and inventory for veterinary healthcare providers

Service providers — offer training, calibration, and digital data management solutions for test implementation

Regulatory authorities — establish validation standards and approval pathways for diagnostic accuracy and performance

Control points reside in regulatory certification requirements and raw material sourcing, creating dependency risks for manufacturers. Switching costs are elevated due to validation processes for new suppliers, while partnerships between integrators and distributors ensure interoperability across veterinary settings. Regional variations in regulatory frameworks and livestock management practices further shape ecosystem dynamics.

Recent Industry Insights

The veterinary rapid test industry trends over the past 18 months reflect accelerated innovation driven by demand for faster, more accurate diagnostics. Key players have formed strategic partnerships to expand global reach, such as diagnostic firms collaborating with veterinary networks to integrate point-of-care testing solutions. Notable mergers & acquisitions include Zoetis acquiring a niche rapid test developer to bolster its infectious disease portfolio, while product/technology launches highlight advances in multiplex assays for zoonotic pathogens and AI-driven test interpretation tools. Regulatory bodies like the FDA have expedited approvals for tests targeting emerging animal diseases, such as avian influenza, reshaping compliance frameworks. Meanwhile, rising pet humanization and outbreaks of livestock diseases have shifted consumer and enterprise trends toward proactive health monitoring, boosting demand for at-farm and at-home testing. Funding rounds have surged, with startups securing Series B investments to scale production of portable diagnostic devices, signaling long-term confidence in decentralized testing models.

Analyst Overview

The veterinary rapid test market is poised for robust growth, driven by rising zoonotic disease concerns, increased pet humanization, and advancements in diagnostic technologies. Market attractiveness is enhanced by expanding applications in both companion and livestock animals, with emerging economies offering untapped potential. Competitive intensity remains moderate, characterized by strategic collaborations between established players and niche innovators, though pricing pressures and regulatory hurdles may temper immediate gains.

The long-term outlook for the veterinary rapid test market outlook is optimistic, supported by digitization trends and demand for point-of-care solutions. Innovation landscape is dynamic, with AI-integrated tools and multiplex testing platforms gaining traction. However, demand–supply balance faces challenges in specialized tests, where R&D cycles lag behind emerging needs. Key risk factors include stringent regulatory compliance costs, cross-border trade restrictions, and dependency on raw material supply chains. Strategic investments in R&D and partnerships will be critical for sustaining growth.

11 items

1. Executive Summary

2. veterinary rapid test Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global veterinary rapid test Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global veterinary rapid test Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Veterinary Hospitals and Clinics

6.1.2. Laboratories

6.2. Global veterinary rapid test Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Companion Test

6.2.2. Livestock Test

6.3. Global veterinary rapid test Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global veterinary rapid test Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global veterinary rapid test Market by: Regions (Value)

8. Global veterinary rapid test Market Competition by Key Manufacturers

8.1. Global veterinary rapid test Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global veterinary rapid test: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. IDEXX Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zoetis

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Virbac

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Thermo Fisher Scientific

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. SafePath Laboratories

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BioNote

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Heska

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Fassisi

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Chembio Diagnostic Systems

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bio-X Diagnostics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. QUICKING BIOTECH

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. DRG International

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Woodley Equipment Company

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. ScheBo Biotech

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. LifeAssays

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Biopanda Reagents

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. SWISSAVANS

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. MEGACOR Diagnostik

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global veterinary rapid test Market

Figure 4: Global veterinary rapid test Market: Drivers

Figure 5: Global veterinary rapid test Market: Challenges

Figure 6: Global veterinary rapid test Market: Trends

Figure 7: Global veterinary rapid test Market: Opportunity

Figure 8: Global veterinary rapid test Market: Restraint

Figure 9: Global veterinary rapid test Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global veterinary rapid test Market Value (USD Million) By Region

Figure 15: Global veterinary rapid test Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global veterinary rapid test Market Value (USD Million) By Region

Figure 23: Global veterinary rapid test Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global veterinary rapid test Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global veterinary rapid test Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global veterinary rapid test Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global veterinary rapid test Market Value (USD Million) By Region

Table 10: Global veterinary rapid test Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global veterinary rapid test Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global veterinary rapid test Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global veterinary rapid test Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: IDEXX Laboratories Basic Information And Sales Area

Table 31: IDEXX Laboratories. Products Portfolio

Table 32: Zoetis Basic Information And Sales Area

Table 33: Zoetis. Products Portfolio

Table 34: Virbac Basic Information And Sales Area

Table 35: Virbac. Products Portfolio

Table 36: Thermo Fisher Scientific Basic Information And Sales Area

Table 37: Thermo Fisher Scientific. Products Portfolio

Table 38: SafePath Laboratories Basic Information And Sales Area

Table 39: SafePath Laboratories. Products Portfolio

Table 40: BioNote Basic Information And Sales Area

Table 41: BioNote. Products Portfolio

Table 42: Heska Basic Information And Sales Area

Table 43: Heska. Products Portfolio

Table 44: Fassisi Basic Information And Sales Area

Table 45: Fassisi. Products Portfolio

Table 46: Chembio Diagnostic Systems Basic Information And Sales Area

Table 47: Chembio Diagnostic Systems. Products Portfolio

Table 48: Bio-X Diagnostics Basic Information And Sales Area

Table 49: Bio-X Diagnostics. Products Portfolio

Table 50: QUICKING BIOTECH Basic Information And Sales Area

Table 51: QUICKING BIOTECH. Products Portfolio

Table 52: DRG International Basic Information And Sales Area

Table 53: DRG International. Products Portfolio

Table 54: Woodley Equipment Company Basic Information And Sales Area

Table 55: Woodley Equipment Company. Products Portfolio

Table 56: ScheBo Biotech Basic Information And Sales Area

Table 57: ScheBo Biotech. Products Portfolio

Table 58: LifeAssays Basic Information And Sales Area

Table 59: LifeAssays. Products Portfolio

Table 60: Biopanda Reagents Basic Information And Sales Area

Table 61: Biopanda Reagents. Products Portfolio

Table 62: SWISSAVANS Basic Information And Sales Area

Table 63: SWISSAVANS. Products Portfolio

Table 64: MEGACOR Diagnostik Basic Information And Sales Area

Table 65: MEGACOR Diagnostik. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global veterinary rapid test Market Value (USD Million) By Region

Table 71: Global veterinary rapid test Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

veterinary rapid test Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.04 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	IDEXX Laboratories; Zoetis; Virbac; Thermo Fisher Scientific; SafePath Laboratories; BioNote; Heska; Fassisi; Chembio Diagnostic Systems; Bio-X Diagnostics; QUICKING BIOTECH; DRG International; Woodley Equipment Company; ScheBo Biotech; LifeAssays; Biopanda Reagents; SWISSAVANS; MEGACOR Diagnostik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options